Excluding gains from the sale of Target's pharmacy and clinic
business and restructuring charges, earnings stood at $1.29 per
share in the first quarter ended on April 30.
Analysts on average were expecting $1.20 per share, according to
Thomson Reuters I/B/E/S.
Sales at stores open for at least a year rose 1.2 percent, less
than the market consensus of 1.6 percent, according to research
firm Consensus Metrix.
(Reporting by Nandita Bose in Chicago; Editing by Lisa Von Ahn)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|